01 Sanofi-aventis Deutschland GmbH (10)
02 ELI LILLY NEDERLAND BV (11)
03 Eli Lilly (Suisse) SA (8)
04 Eli Lilly Nederland B.V. (1)
05 Eli Lilly Nederland BV (7)
06 Eli Lilly Norge AS (2)
07 Farm Agon (1)
08 Novo Nordisk A/S (13)
01 Insulin Lispro (53)
01 Italy (11)
02 Norway (34)
03 Switzerland (8)
01 Injection (8)
02 Injection fluid, resolution (11)
03 Injection fluid, resolution in the finished filled pen (1)
04 Injection fluid, suspension (22)
05 Insulin Lispro From Recombinant Dna 1.000Iu 10Ml 1 Units Parenteral Use (1)
06 Insulin Lispro From Recombinant Dna 200Iu/Ml 3Ml 5 Units Parenteral Use (1)
07 Insulin Lispro From Recombinant Dna 300Iu 3Ml 5 Units Parenteral Use (2)
08 Insulin Lispro From Recombinant Dna+Insulin Lispro Protamine 25 1.000Iu 10Ml 1 Units Parenteral Use (1)
09 Insulin Lispro From Recombinant Dna+Insulin Lispro Protamine 25 300Iu 3Ml 5 Units Parenteral Use (2)
10 Insulin Lispro From Recombinant Dna+Insulin Lispro Protamine 50 300Iu 3Ml 5 Units Parenteral Use (2)
11 Insulin Lispro Protamine Suspension 300Iu 3Ml 5 Units Parenteral Use (2)